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In this issue of the European Journal of Nuclear Medicine
and Molecular Imaging, Flotats et al. [1] report a striking
improvement in image quality of myocardial perfusion
studies with the use of 82Rb PET/CT as compared to con-
ventional 99mTc-labelled SPECT/CT. When using PET/CT
in concert with the positron-emitting myocardial perfusion
tracer 82Rb, the improvement in image quality also mani-
fested in a higher interpretative confidence and interreader
agreement of 82Rb perfusion images than observed for
99mTc-labelled SPECT/CT. In particular, the current study
is unique in that 82Rb PET/CT and 99mTc-labelled SPECT/
CT were performed in the same patient with known or
suspected coronary artery disease (CAD). Previous inves-
tigations commonly compared the sensitivity and specificity
of cardiac PET versus SPECT perfusion imaging in the
detection of flow-limiting epicardial lesions [2]. For exam-
ple, Go et al. [3] showed sensitivity, specificity and accuracy
of 95, 82 and 92 % for 82Rb PET and 79, 76 and 78 % for
201Tl SPECT for haemodynamically obstructive CAD
lesions. Further, Stewart et al. [4] reported that overall
sensitivity, specificity and accuracy of 82Rb PET for detec-
tion of coronary artery lesions ≥50 % diameter stenosis were
84, 88 and 85 %, respectively. In comparison to this, the
performance of 201Tl SPECT revealed a sensitivity of 84 %
but a low specificity of 53 % and a diagnostic accuracy of
79 %. The commonly higher sensitivity in the identification
of flow-limiting epicardial lesions with 82Rb PET as
compared with SPECT imaging, either with 201Tl or
99mTc-labelled perfusion tracers, can be related to the higher
spatial and contrast resolution of 82Rb PET, while the pho-
ton attenuation–free images of PET imaging may account
for the relative increase in specificity [2].
The new investigation conducted by Flotats et al. [1] now
adds further important information by addressing image
quality of myocardial perfusion studies, and the resulting
reader confidence, and interreader agreement when applying
82Rb PET/CT in direct comparison to 99mTc-labelled
SPECT/CT. As it was observed, image quality was estimated
to be excellent or good in 63 % of PET, 33 % of attenuation-
corrected (AC) SPECT and 22 % of non-AC SPECT
images. Further, artefact-free images were more frequently
observed with PET than with SPECT studies (PET 81 %,
AC SPECT 22 % and non-AC SPECT 15 %). In this
direction, significant liver or bowel uptake (or both) as well
as attenuation artefacts can be assumed to have substantially
affected the interpretation of the SPECT/CT images render-
ing the interpretative decision-making process more difficult
or observer dependent for SPECT/CT than for PET/CT
images. Not surprisingly, the reader certitude to grade
stress-rest perfusion imaging into a normal or abnormal
finding was highest for PET (85 %), followed by AC
SPECT (30 %) and non-AC SPECT (7 %). This is also
reflected by the interreader agreement which was superior
for PET/CT than for those of SPECT/CT perfusion studies.
Several methodological aspects may account for the
observations of Flotats et al. [1]. PET cameras identify
paired photons (511 keV of energy each) produced by the
positron annihilation effect. The paired 511 keV travel in the
opposite direction at a 180° angle from each other [2]. This
enables a precise localization of the positron decay applying
the principle of coincidence detection and without collima-
tion as used for SPECT [2, 5]. Without the use of collima-
tors, PET cameras have a much higher sensitivity than do
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SPECT cameras, resulting in a higher spatial resolution in
the range of 4–7 mm. Another aspect is the relatively higher
extraction fraction of 82Rb at higher flows than those of
99mTc-labelled perfusion tracers [6], which yields an in-
crease in contrast resolution. Both the higher spatial and
contrast resolution of 82Rb PET perfusion studies explain
the reported higher sensitivity in the detection of CAD
lesions as compared with 201Tl or 99mTc-labelled perfusion
tracers [2, 6]. Conversely, the robust attenuation correction
of the PET emission data using the transmission source
(68Ge rotating rod source or CT) accounts for the reported
increase in specificity of PET perfusion imaging when
compared to conventional SPECT imaging [2, 7].
Another important aspect is that the gamma energy levels
of PET radiotracers with 511 keV are considerably higher
than those for 99mTc-labelled perfusion tracers (140 keV)
and 201Tl (70-90 keV) applied in cardiac SPECT imaging.
This again renders PET imaging less prone to attenuation
artefacts. Conceptually, although the two 511-keV photons
produced by positron annihilations are less attenuated than a
single 140-keV 99mTc photon, there may be in fact more
attenuation with PET than with SPECT imaging as two
photons must be identified for coincidence detection.
According to the principle of coincidence detection, how-
ever, the two photons travelling in opposite directions proj-
ect along the same ray and they must pass through the same
total amount of tissue independent of the localization where
they were emitted [8]. The total measured attenuation in
PET imaging therefore can be assumed to be similar any-
where along this projection line. This is in contrast to
SPECT imaging, where there is no opposing photon in order
to aid in localizing an annihilation event. Because of this,
attenuation of photons in SPECT imaging can vary expo-
nentially. PET emission data therefore can be precisely
corrected for attenuation by simply multiplying each projec-
tion line with the appropriate AC factors determined from a
transmission 68Ge line source or CT as compared to more
complicated ones applied for SPECT [8]. The higher gamma
energy levels of PET radiotracers with 511 keV and very
solid and precise attenuation correction of PET emission
data do not lead only to an increase in specificity but also
to an increase in interpretative confidence of PET perfusion
images as observed in the current study [1]. The technolog-
ical advantages of PET over SPECT cameras, therefore,
have led to a relatively higher sensitivity and specificity
of myocardial perfusion PET or PET/CT scanners for
detecting ≥50 or ≥70 % luminal epicardial narrowing
around 92 and 90 %, respectively [2]. On the other hand,
we need to bear in mind that reported PET or PET/CT
perfusion studies were mostly performed in highly selected
study populations, which may have biased, at least in part,
the relatively high sensitivity and specificity of PET perfu-
sion studies in the detection of CAD lesions. The high
spatial and contrast resolution in concert with photon
attenuation–free images of PET, however, provide a higher
image quality associated with a higher sensitivity and
specificity of PET/CT perfusion imaging than for conven-
tional SPECT or SPECT/CT. This again may explain the
relative ease in the interpretation of PET/CT stress-rest
perfusion images for the detection of flow-limiting epicar-
dial lesions [1].
How current observations of Flotats et al. [1] with 82Rb
PET/CT myocardial perfusion imaging compare with itera-
tive image reconstruction or the implementation of new
algorithms, so-called proprietary resolution recovery/noise
reduction (RRNR) of SPECT/CT systems, or new ultrafast
SPECT camera designs [8, 9], remain uncertain, which will
certainly stimulate further comparative investigations and
advancements in the field of scintigraphic myocardial
perfusion imaging [10].
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